Literature DB >> 25125473

Phosphodiesterase inhibition in cognitive decline.

Carolina García-Barroso1, Ana Ugarte2, Martín Martínez3, Alberto J Rico4, José Luis Lanciego4, Rafael Franco1, Julen Oyarzabal2, Mar Cuadrado-Tejedor5, Ana García-Osta1.   

Abstract

Understanding the cellular and molecular processes involved in learning and memory will help in the development of safe and effective cognitive enhancers. The cAMP response element-binding (CREB) may be a universal modulator of processes required for memory formation, and increasing the levels of second messengers like cAMP and cGMP could ultimately lead to CREB activation. Phosphodiesterase (PDE) inhibitors regulate signaling pathways by elevating cAMP and/or cGMP levels, and they have been demonstrated to improve learning and memory in a number of rodent models of impaired cognition. The aim of this review is to summarize the outstanding progress that has been made in the application of PDE inhibitors for memory dysfunction. In addition, we have introduced some recent data we generated demonstrating that tadalafil could be considered as an optimal candidate for drug re-positioning and as a good candidate to enhance cognition.

Entities:  

Keywords:  Cerebrospinal fluid; cGMP; memory enhancement; phosphodiesterase; tadalafil

Mesh:

Substances:

Year:  2014        PMID: 25125473     DOI: 10.3233/JAD-141341

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  Roles of roflumilast, a selective phosphodiesterase 4 inhibitor, in airway diseases.

Authors:  Theerasuk Kawamatawong
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

2.  Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.

Authors:  Patrick M McDonough; Natalie L Prigozhina; Ranor C B Basa; Jeffrey H Price
Journal:  Assay Drug Dev Technol       Date:  2017-07       Impact factor: 1.738

3.  Rolipram treatment during consolidation ameliorates long-term object location memory in aged male mice.

Authors:  Mathieu E Wimmer; Jennifer M Blackwell; Ted Abel
Journal:  Neurobiol Learn Mem       Date:  2020-01-19       Impact factor: 2.877

4.  Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.

Authors:  Ke Ke; Ali Muhammad Safder; Ok-Joo Sul; Jae-Hee Suh; Yeonsoo Joe; Hun-Taeg Chung; Hye-Seon Choi
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

5.  Enhancing cognition before clinical symptoms of dementia.

Authors:  Rafael Franco
Journal:  Front Syst Neurosci       Date:  2014-12-16

Review 6.  MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

Authors:  Wissem Deraredj Nadim; Viorel Simion; Helene Benedetti; Chantal Pichon; Patrick Baril; Severine Morisset-Lopez
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

7.  Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression.

Authors:  Raphael Hesse; Ludwig Lausser; Pauline Gummert; Florian Schmid; Anke Wahler; Cathrin Schnack; Katja S Kroker; Markus Otto; Hayrettin Tumani; Hans A Kestler; Holger Rosenbrock; Christine A F von Arnim
Journal:  Alzheimers Res Ther       Date:  2017-03-09       Impact factor: 6.982

Review 8.  Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.

Authors:  Haitao Wang; Uma Gaur; Jiao Xiao; Bingtian Xu; Jiangping Xu; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

Review 9.  A Perspective on Natural and Nature-Inspired Small Molecules Targeting Phosphodiesterase 9 (PDE9): Chances and Challenges against Neurodegeneration.

Authors:  Giovanni Ribaudo; Maurizio Memo; Alessandra Gianoncelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

10.  Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats.

Authors:  Bart de Laat; Yvonne E Kling; Gwen Schroyen; Maarten Ooms; Jacob M Hooker; Guy Bormans; Koen Van Laere; Jenny Ceccarini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-17       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.